Inactive Instrument

Highlights Pressure BioSciences, Inc. Other OTC

Equities

PBIO

US74112E2081

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

Pressure BioSciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	08/06	CI
Pressure BioSciences, Inc. Completes Relocation into New Manufacturing Facility, Consolidating R&D with Expanded UltraShear Equipment Development and Contract Manufacturing	15/02	CI
Pressure BioSciences, Inc. completed the acquisition of CBH International LLC.	22/01	CI
Pressure BioSciences, Inc. Receives Open Order Agreement from West Coast Manufacturing Partner	18/01	CI
Pressure BioSciences, Inc. entered into a definitive agreement to acquire CBH International LLC.	11/01	CI
Pressure BioSciences' BaroFold Platform Expected to Revolutionize Biopharmaceutical Production with Help from New Computational (AI/ML) Technologies	04/01	CI
Pressure BioSciences, Inc. Announces the Publication of Pivotal Scientific Study in the Critical Field of Food Safety	12/12	CI
Pressure BioSciences and Veterans Service Team Launch UltraShear Best-in-Class Nano-CBD Topical Spray - MMA Champ Cat Zingano Now Official VST Ambassador	01/12	CI
Earnings Flash (PBIO) PRESSURE BIOSCIENCES Reports Q3 Revenue $413,009	21/11	MT
Pressure BioSciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	21/11	CI
Pressure Biosciences Announces Exclusive Distribution Agreement with Bioscreen Instruments Pvt Ltd	18/23/18	CI
Pressure BioSciences' Partner Veterans Service Team Increases Existing Purchase Order by 10X for Bottles of UltraShear Nano-CBD Topical Spray, Effective Immediately	22/23/22	CI
Earnings Flash (PBIO) PRESSURE BIOSCIENCES Posts Q2 Revenue $511,800	22/23/22	MT
Pressure BioSciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	22/23/22	CI
Pressure BioSciences, Inc. Announces UltraShear Nano-CBD Roll-Out Program Enters Rapid Expansion Phase of Distribution and Partnering	17/23/17	CI
Pressure BioSciences, Inc. Announces UltraShear Processed Nano-CBD Topical Spray Distribution Agreement with Premier CA Cannabis Partner Creme de Canna	10/23/10	CI
Pressure BioSciences, Inc. Announces Agreement with Somalab International LLC for Development & Distribution of UltraShear-Enabled Nanoemulsified Health and Wellness Products	05/23/05	CI
Pressure Biosciences, Inc. Announces Results from Third Round of Consumer Focus Group Testing of THC Nanoemulsion Oral Spray	27/23/27	CI
Pressure BioSciences, Inc. Partners with Veterans Service Team to Offer Exclusive Access for VST Members to a Unique, Custom-Made, UltraShear Nano-CBD & Other Products	13/23/13	CI
Earnings Flash (PBIO) PRESSURE BIOSCIENCES Posts Q1 Revenue $740,600	16/23/16	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Pressure BioSciences, Inc. Other OTC

Equities

PBIO

US74112E2081

Highlights

Filters